Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder

[1]  H. Akaza,et al.  Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma. , 1995, British journal of urology.

[2]  M. Kerin,et al.  Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma. , 1994, The Journal of urology.

[3]  G. Wilson,et al.  Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry. , 1994, The Journal of urology.

[4]  P. Carroll,et al.  Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. , 1993, Human pathology.

[5]  M. Coptcoat,et al.  Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder--an index of recurrence? , 1993, British journal of urology.

[6]  A. Partin,et al.  The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma. , 1993, The Journal of urology.

[7]  J. Portillo,et al.  Prognostic correlation of morphometric values with survival in invasive transitional cell carcinoma of the bladder. , 1992, British journal of urology.

[8]  P. Lipponen,et al.  Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. , 1992, British Journal of Cancer.

[9]  P. Lipponen,et al.  Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer. , 1991, British Journal of Cancer.

[10]  L. Azzoni,et al.  Argyrophilic Nuclear Organizer Region Counts and Ki-67 Scores in Human Renal Cell Carcinoma , 1991 .

[11]  T. Kurita,et al.  Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining. , 1991, The Journal of urology.

[12]  L. Azzoni,et al.  Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. , 1991, Pathology, research and practice.

[13]  D. Lane,et al.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms , 1990, The Journal of pathology.

[14]  M. Harada,et al.  S‐phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling , 1990 .

[15]  I. Ninomiya,et al.  Growth fractions in gastric carcinomas determined with monoclonal antibody Ki‐67 , 1990, Cancer.

[16]  B. Loftus,et al.  Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores. , 1989, American journal of clinical pathology.

[17]  C. Cornelisse,et al.  Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. , 1989, Cancer research.

[18]  M. Sowa,et al.  An analysis of the DNA ploidy patterns of gastric cancer , 1988, Cancer.

[19]  E. Tan,et al.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. , 1987, Archives of pathology & laboratory medicine.

[20]  R. Asero,et al.  Autoantibody to proliferating cell nuclear antigen (PCNA) in SLE: a clinical and serological study. , 1987, Clinical and experimental rheumatology.

[21]  R. Bravo,et al.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ , 1987, Nature.

[22]  B. Franza,et al.  Identity of the proliferating cell nuclear antigen and cyclin , 1984, Nature.

[23]  B. Barlogie,et al.  Flow cytometry in clinical cancer research. , 1983, Cancer research.

[24]  G. Prout,et al.  Ta and T1 bladder cancer: location, recurrence and progression. , 1982, British journal of urology.